Copper demand has hit a fever pitch.
Investors - see the massive buzz behind this miner.

NASDAQ:LIVN - LivaNova Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $101.00
  • Forecasted Upside: 23.08 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$82.06
▲ +0.02 (0.02%)

This chart shows the closing price for LIVN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New LivaNova Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LIVN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LIVN

Analyst Price Target is $101.00
▲ +23.08% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for LivaNova in the last 3 months. The average price target is $101.00, with a high forecast of $117.00 and a low forecast of $84.00. The average price target represents a 23.08% upside from the last price of $82.06.

This chart shows the closing price for LIVN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in LivaNova. This rating has held steady since April 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/29/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/28/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/26/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/20/2021Needham & Company LLCBoost Price TargetBuy$104.00 ➝ $117.00High
8/17/2021Robert W. BairdBoost Price TargetOutperform$100.00 ➝ $105.00Medium
7/20/2021Needham & Company LLCUpgradeHold ➝ Buy$93.00High
6/7/2021Needham & Company LLCReiterated RatingHoldLow
6/1/2021Piper SandlerLower Price TargetOverweight$99.00 ➝ $98.00High
4/29/2021Robert W. BairdBoost Price TargetOutperform$85.00 ➝ $100.00Low
4/28/2021Piper SandlerBoost Price Target$92.00 ➝ $99.00Low
4/13/2021Piper SandlerBoost Price TargetOverweight$81.00 ➝ $92.00Low
3/9/2021Berenberg BankReiterated RatingBuy ➝ Hold$84.00Medium
3/4/2021Needham & Company LLCReiterated RatingHoldLow
3/3/2021Berenberg BankDowngradeBuy ➝ Hold$84.00High
2/24/2021Piper SandlerBoost Price TargetOverweight$73.00 ➝ $81.00High
1/12/2021Piper SandlerBoost Price TargetOverweight$70.00 ➝ $73.00Medium
1/5/2021Needham & Company LLCDowngradeBuy ➝ HoldN/A
12/15/2020Piper SandlerBoost Price TargetOverweight$63.00 ➝ $70.00High
10/29/2020Piper SandlerBoost Price TargetOverweight$60.00 ➝ $63.00High
10/21/2020Robert W. BairdBoost Price TargetOutperform$55.00 ➝ $65.00Medium
9/1/2020Robert W. BairdInitiated CoverageOutperform$55.00Low
7/29/2020Piper SandlerLower Price TargetPositive ➝ Overweight$65.00 ➝ $60.00Low
7/29/2020Needham & Company LLCLower Price TargetBuy$76.00 ➝ $68.00High
6/26/2020Needham & Company LLCLower Price TargetBuy$84.00 ➝ $76.00High
4/30/2020Canaccord GenuityLower Price TargetHold$66.00 ➝ $50.00High
4/30/2020UBS GroupLower Price TargetNeutral$70.00 ➝ $57.00Medium
4/29/2020Piper SandlerLower Price TargetOverweight$80.00 ➝ $65.00Low
3/24/2020Stifel NicolausLower Price TargetBuy$80.00 ➝ $40.00High
2/27/2020Berenberg BankReiterated RatingBuy$114.00High
2/27/2020Canaccord GenuityReiterated RatingHold$66.00High
11/25/2019Stifel NicolausBoost Price TargetBuy$80.00 ➝ $90.00High
11/20/2019Needham & Company LLCReiterated RatingBuy$88.00Low
10/30/2019Needham & Company LLCLower Price TargetBuy$91.00 ➝ $88.00Medium
9/9/2019Berenberg BankReiterated RatingBuy$114.00Low
9/6/2019Piper Jaffray CompaniesSet Price TargetBuy$90.00Low
9/6/2019Needham & Company LLCReiterated RatingBuy$91.00Medium
7/31/2019Needham & Company LLCSet Price TargetBuy$91.00Medium
7/31/2019Piper Jaffray CompaniesReiterated RatingBuyN/A
7/31/2019BTIG ResearchReiterated RatingHoldN/A
5/28/2019Needham & Company LLCReiterated RatingBuy$87.00Low
5/15/2019Needham & Company LLCReiterated RatingBuy$87.00Low
5/2/2019BTIG ResearchReiterated RatingHoldHigh
5/1/2019Piper Jaffray CompaniesLower Price TargetOverweight ➝ In-Line$120.00 ➝ $90.00High
4/9/2019Needham & Company LLCReiterated RatingBuy$100.00Low
4/5/2019Stifel NicolausReiterated RatingBuy$100.00Medium
4/2/2019UBS GroupBoost Price TargetNeutral$100.00 ➝ $105.00Low
3/5/2019BTIG ResearchReiterated RatingHoldLow
2/27/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$135.00 ➝ $120.00High
11/27/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$105.00High
11/21/2018BTIG ResearchReiterated RatingHoldLow
11/1/2018BTIG ResearchReiterated RatingHoldMedium
10/2/2018Jefferies Financial GroupBoost Price TargetBuy$150.00Low
9/17/2018Stifel NicolausBoost Price TargetBuy$135.00 ➝ $140.00Low
8/2/2018Stifel NicolausReiterated RatingBuy$135.00Medium
8/1/2018Needham & Company LLCReiterated RatingBuy$128.00 ➝ $135.00High
7/24/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$115.00 ➝ $130.00High
7/18/2018Needham & Company LLCReiterated RatingBuy$128.00Low
6/8/2018Stifel NicolausInitiated CoverageBuy$115.00Medium
5/31/2018Needham & Company LLCReiterated RatingBuy$102.00 ➝ $106.00High
5/3/2018BTIG ResearchReiterated RatingHoldLow
2/28/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$97.00 ➝ $104.00Low
2/27/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$76.00 ➝ $81.00Low
12/5/2017Canaccord GenuityReiterated RatingHold$76.00Low
12/5/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$93.00 ➝ $97.00Low
11/21/2017Needham & Company LLCBoost Price TargetBuy$93.00N/A
11/14/2017Canaccord GenuityReiterated RatingHold$76.00N/A
11/7/2017BTIG ResearchReiterated RatingHoldN/A
11/3/2017Piper Jaffray CompaniesReiterated RatingBuy$85.00N/A
11/3/2017Jefferies Financial GroupBoost Price TargetBuy$80.00 ➝ $91.00N/A
11/3/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$83.00 ➝ $89.00N/A
9/20/2017Canaccord GenuityReiterated RatingHold$71.00Low
9/15/2017Jefferies Financial GroupBoost Price TargetBuy$76.00 ➝ $80.00Low
9/15/2017Needham & Company LLCUpgradeHold ➝ Buy$83.00Low
9/14/2017Needham & Company LLCUpgradeHold ➝ Buy$83.00High
9/12/2017Piper Jaffray CompaniesReiterated RatingOverweight ➝ Overweight$75.00Low
9/8/2017Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$76.00High
8/23/2017Needham & Company LLCInitiated CoverageHold ➝ HoldLow
8/15/2017WBB SecuritiesDowngradeHold ➝ Sell$50.00Low
8/11/2017Berenberg BankReiterated RatingBuy$70.00Low
3/10/2017BTIG ResearchReiterated RatingHoldN/A
2/6/2017Canaccord GenuityReiterated RatingHold$54.00N/A
11/3/2016Canaccord GenuityLower Price TargetHold$67.00 ➝ $54.00N/A
(Data available from 9/24/2016 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/26/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/28/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/27/2021
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2021
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/26/2021
  • 3 very positive mentions
  • 25 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2021
  • 3 very positive mentions
  • 17 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
9/24/2021

Current Sentiment

  • 3 very positive mentions
  • 17 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
LivaNova logo
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the Cardiovascular and Neuromodulation segments. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and circulatory support products. The Neuromodulation segment designs, develops, and markets Neuromodulation therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression (DTD), and obstructive sleep apnea. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $82.06
Low: $81.60
High: $82.82

50 Day Range

MA: $82.55
Low: $76.02
High: $88.62

52 Week Range

Now: $82.06
Low: $41.07
High: $90.25

Volume

551,041 shs

Average Volume

399,434 shs

Market Capitalization

$4.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Frequently Asked Questions

What sell-side analysts currently cover shares of LivaNova?

The following Wall Street analysts have issued reports on LivaNova in the last year: Berenberg Bank, Needham & Company LLC, Piper Sandler, Robert W. Baird, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for LIVN.

What is the current price target for LivaNova?

4 Wall Street analysts have set twelve-month price targets for LivaNova in the last year. Their average twelve-month price target is $101.00, suggesting a possible upside of 23.1%. Needham & Company LLC has the highest price target set, predicting LIVN will reach $117.00 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of $84.00 for LivaNova in the next year.
View the latest price targets for LIVN.

What is the current consensus analyst rating for LivaNova?

LivaNova currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LIVN will outperform the market and that investors should add to their positions of LivaNova.
View the latest ratings for LIVN.

What other companies compete with LivaNova?

How do I contact LivaNova's investor relations team?

LivaNova's physical mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The company's listed phone number is 442033250660 and its investor relations email address is [email protected] The official website for LivaNova is www.livanova.com.

Since 2019 why has this stock soared as much as 9000+% ?
Livestreaming and digital currencies will never be the same. That's because this disruptor's come along.

The only public company with direct exposure to a coin up 5500+% YTD. And it’s a livestreaming platform.